化合物 T16947
|
|
- CAS号:
- 251356-45-3
- 英文名:
- SU 16f
- 英文别名:
- SU 16f;PDGFR Tyrosine Kinase Inhibitor VII - CAS 251356-45-3 - Calbiochem;(Z)-3-(2,4-Dimethyl-5-((2-oxo-6-phenylindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid;5-[1,2-Dihydro-2-oxo-6-phenyl-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoicacid;1H-Pyrrole-3-propanoic acid, 5-[(1,2-dihydro-2-oxo-6-phenyl-3H-indol-3-ylidene)methyl]-2,4-dimethyl-;3-{2,4-dimethyl-5-[(2-oxo-6-phenyl-2,3-dihydro-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid
- 中文名:
- 化合物 T16947
- 中文别名:
- 化合物SU16F;化合物 T16947;SU 16F,PDGFRΒ抑制剂
- CBNumber:
- CB42501833
- 分子式:
- C24H22N2O3
- 分子量:
- 386.44
- MOL File:
- 251356-45-3.mol
|
|
|
化合物 T16947化学性质
-
沸点:
-
661.7±55.0 °C(Predicted)
-
|
-
密度:
-
1.292±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at RT
-
|
-
溶解度:
-
Soluble to 100 mM in DMSO
-
|
-
形态:
-
Dark orange solid
-
|
-
酸度系数(pKa):
-
4?+-.0.10(Predicted)
-
|
-
颜色:
-
Yellow to orange
-
|
化合物 T16947性质、用途与生产工艺
SU16f 是有效的,选择性 PDGFRβ 抑制剂,对 PDGFRβ,PDGFR1,PDGFR2 的 IC50 分别为 10 nM,140 nM,2.29 μM。SU16f 抑制 PDGFRβ 受体从而可以阻断胃癌来源的间充质干细胞 (GC-MSC) 条件培养基在胃癌细胞增殖和迁移中的促进作用。
PDGFRβ
10 nM (IC
50
)
|
PDGFR2
140 nM (IC
50
)
|
PDGFR1
2.29 μM (IC
50
)
|
SU16f (20 μM; for 8 hours) pretreatment inhibits the promoting role of GC-MSC-CM in SGC-7901 cell proliferation.
SU16f (20 μM; for 8 hours) significantly abolishes PDGFRβ activation in SGC-7901 by GC-MSC-CM. SU16f pretreatment results in the upregulation of E-cadherin and downregulation of N-cadherin, Vimentin, and α-SMA. SU16f pretreatment leads to downregulation of p-AKT, Bcl-xl, and Bcl-2 levels and upregulation of Bax expression in SGC-7901 cells by GC-MSC-CM .
Cell Proliferation Assay
Cell Line:
|
SGC-7901 cells in GC-MSC/SGC-7901 co-culture system
|
Concentration:
|
20 μM
|
Incubation Time:
|
8 hours
|
Result:
|
Inhibited the promoting role of GC-MSC-CM in SGC-7901 cell proliferation.
|
Western Blot Analysis
Cell Line:
|
SGC-7901 cells
|
Concentration:
|
20 μM
|
Incubation Time:
|
8 hours
|
Result:
|
Significantly abolished PDGFRβ activation in SGC-7901 by GC-MSC-CM, and resulted in the upregulation of E-cadherin and downregulation of N-cadherin, Vimentin, and α-SMA.
|
化合物 T16947
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/08/19 | HY-108628 | 化合物 T16947 SU16f | 251356-45-3 | 1 mg | 480元 |
2024/08/19 | HY-108628 | 化合物 T16947 SU16f | 251356-45-3 | 5mg | 980元 |
251356-45-3, 化合物 T16947 相关搜索:
- Angiogenesis and Metastasis
- 抑制剂
- 标准品
- 酶
- SU 16F,PDGFRΒ抑制剂
- 化合物SU16F
- 化合物 T16947
- 251356-45-3
- 3-{2,4-dimethyl-5-[(2-oxo-6-phenyl-2,3-dihydro-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid
- 1H-Pyrrole-3-propanoic acid, 5-[(1,2-dihydro-2-oxo-6-phenyl-3H-indol-3-ylidene)methyl]-2,4-dimethyl-
- PDGFR Tyrosine Kinase Inhibitor VII - CAS 251356-45-3 - Calbiochem
- SU 16f
- (Z)-3-(2,4-Dimethyl-5-((2-oxo-6-phenylindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
- 5-[1,2-Dihydro-2-oxo-6-phenyl-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoicacid